logo
Sign in

NEO Stock Price, Chart, Stats & News

290.37M
Market cap
Current P/E
222.22x
Forward P/E

NEO chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
42.16%
Operating margin
-15.62%
Pretax margin
-15.16%
Net margin
-14.85%
Effective tax rate
2.03%
ROA
-7.94%
ROE
-12.64%
D/E
0.56x
Interest coverage ratio
-30.27x

NEO valuation

P/E
P/S
0.26x
P/B
0.22x
P/CF
35.37x
P/FCF
-8.57x
P/OCF
35.37x
PEG
-0.38x
EV multiple
3.26x

About

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers.

Similar securities

Based on sector and market capitalization

Report issue